ArticleJournal for immunotherapy of cancer2024

Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes.

Amin H Nassar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.